CME Froze the First SEC-Approved Bitcoin Index Options — and Put the Bitcoin Commodity Question Back Before the Commission
The SEC granted CME Group's petition to review its conditional May 2026 approval of Nasdaq PHLX's cash-settled Bitcoin index options, publishing the order in the Federal Register on August 3 and setting August 24 as the deadline for public comment; the original approval is automatically stayed, freezing the product's launch indefinitely. CME argues Bitcoin is a non-security commodity under exclusive CFTC jurisdiction and that allowing a securities exchange to list direct Bitcoin index options would displace the CFTC-regulated Bitcoin derivatives market where CME holds dominant volume through its own Bitcoin futures and micro-futures contracts. Nasdaq's QBTC tracks the CME CF Bitcoin Real-Time Index — meaning CME's own index underlies the product CME moved to block. The review will test whether the SEC can clear Bitcoin-linked products at all when a CFTC-regulated exchange holds a jurisdictional counterclaim, a question the CLARITY Act would resolve by statute but that stalled in the Senate before its August recess.
The SEC's grant of CME's petition places the question of Bitcoin's commodity classification — and which federal regulator governs its derivatives market — formally back before the Commission at the moment when statutory resolution through the CLARITY Act is most uncertain.
